Literature DB >> 14975485

Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis.

Alain Cribier1, Hélène Eltchaninoff, Christophe Tron, Fabrice Bauer, Carla Agatiello, Laurent Sebagh, Assaf Bash, Danielle Nusimovici, P Y Litzler, Jean-Paul Bessou, Martin B Leon.   

Abstract

OBJECTIVES: This study was done to assess the results of percutaneous heart valve (PHV) implantation in non-surgical patients with end-stage calcific aortic stenosis.
BACKGROUND: Replacement of PHV has been shown to be feasible in animals and humans. We developed a PHV composed of three pericardial leaflets inserted within a balloon-expandable stainless steel stent. We report the acute and early follow-up results of the initial six PHV implantations.
METHODS: An anterograde approach was used in all cases. The PHV, crimped over a 22-mm diameter balloon, was advanced through a 24-F sheath from the femoral vein to the aortic valve and delivered by balloon inflation. Clinical, hemodynamic, and echocardiographic outcomes were assessed serially.
RESULTS: All patients were in New York Heart Association functional class IV. The PHV was successfully delivered in five patients. Early migration with subsequent death occurred in one patient who presented with a torn native valve. Acute hemodynamic and angiographic results showed no residual gradient, mild (three patients) or severe (two patients) aortic regurgitation, and patent coronary arteries. On echocardiography, the aortic valve area was increased from 0.5 +/- 0.1 cm(2) to 1.70 +/- 0.03 cm(2) and the aortic regurgitation was paravalvular. Marked and sustained hemodynamic and clinical improvement was observed after successful PHV implants. The first three patients died of a non-cardiac cause at 18, 4, and 2 weeks, respectively, and the other patients are alive at 8 weeks with no signs of heart failure.
CONCLUSIONS: Implantation of the PHV can be achieved in patients with end-stage calcific aortic stenosis and might become an important therapeutic option for patients not amenable to surgical valve replacement.

Entities:  

Mesh:

Year:  2004        PMID: 14975485     DOI: 10.1016/j.jacc.2003.11.026

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  82 in total

Review 1.  Which strategy for a protein crystallization project?

Authors:  C E Kundrot
Journal:  Cell Mol Life Sci       Date:  2004-03       Impact factor: 9.261

Review 2.  Amyloid fibrils from the viewpoint of protein folding.

Authors:  S Ohnishi; K Takano
Journal:  Cell Mol Life Sci       Date:  2004-03       Impact factor: 9.261

Review 3.  [Transcatheter aortic valve implantation : what do anesthetists need to know?].

Authors:  C Riediger; F Nietlispach; F Rüter; J Fassl
Journal:  Anaesthesist       Date:  2011-12       Impact factor: 1.041

4.  Current status of percutaneous valvular procedures.

Authors:  Dominique Himbert; Eric Brochet; David Messika-Zeitoun; Alec Vahanian
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-11

5.  Temporary support with Tandemheart pVAD during percutaneous aortic valve replacement in an animal model: rationale and methodology.

Authors:  Biswajit Kar; Reynolds M Delgado; Andrew B Civitello; Pranav Loyalka; David Paniagua; R David Fish; Matthew D Forrester; Daniel Moser; Branislav Radovancevic
Journal:  Tex Heart Inst J       Date:  2005

6.  Aortic valve replacement vs. transcatheter aortic valve implantation: Patient selection.

Authors:  Jian Ye; Jia Lin Soon; John Webb
Journal:  Ann Cardiothorac Surg       Date:  2012-07

Review 7.  Percutaneous approaches to valvular heart disease.

Authors:  Peter C Block; Philipp Bonhoeffer
Journal:  Curr Cardiol Rep       Date:  2005-03       Impact factor: 2.931

8.  Closed bore XMR (CBXMR) systems for aortic valve replacement: active magnetic shielding of x-ray tubes.

Authors:  John A Bracken; Giovanni DeCrescenzo; Philip Komljenovic; Prasheel V Lillaney; Rebecca Fahrig; J A Rowlands
Journal:  Med Phys       Date:  2009-05       Impact factor: 4.071

9.  [Fast track in cardiac surgery].

Authors:  M Strüber; M Winterhalter
Journal:  Chirurg       Date:  2009-08       Impact factor: 0.955

10.  Midterm results of transapical aortic valve replacement via real-time magnetic resonance imaging guidance.

Authors:  Keith A Horvath; Dumitru Mazilu; Michael Guttman; Arthur Zetts; Timothy Hunt; Ming Li
Journal:  J Thorac Cardiovasc Surg       Date:  2009-12-06       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.